YAGI Toshiaki

• 4P-031(WS57-6) Poster: October 22 (Sat) 12:15 Room Poster (Hall No.1 1F/2F, Hall No.2 1F, Kobe International Exhibition Hall) / Workshop: October 21 (Fri) 15:30 Room H (Kairaku 3, Main Building B1F, Kobe Portopia Hotel)
  A gain-of-function derivative from anti-apoptotic Bcl-x_L, the FNK protein prevents hearing-loss, a side-effect of anti-cancer cisplatin: Ken-ichi Watanabe, Sadamitsu Asoh, Kumi Yamagata, Toshiaki Yagi, Shigeo Ohta Keywords: ANTICANCER-DRUG; NEURONAL-CELL-DEATH; NEURONAL-DISORDER